Oral pulmonary vasoactive drugs achieve hemodynamic eligibility for liver transplantation in portopulmonary hypertension.

Ludivine Legros,Céline Chabanne,Christophe Camus,Maxime Fournet,Pauline Houssel-Debry,Marianne Latournerie,Caroline Jezequel,Michel Rayar,Karim Boudjema,Dominique Guyader,Edouard Bardou-Jacquet

Digestive and Liver Disease（2017）

引用 14|浏览20

暂无评分

摘要

Oral pulmonary vasoactive drugs are safe in cirrhotic patients with POPH. These treatments improved hemodynamic conditions allowing patients access to liver transplantation eligibility.

查看译文

关键词

Cirrhosis,Liver transplantation,Portal hypertension,Pulmonary artery hypertension

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要